References
w1 Market Opinion and Research International.
Women’s health in 1990. Research conducted on behalf of Parke Davies
Research Laboratories, Cambridge: MORI, 1990.
w2 Royal College of Obstetrics and Gynaecology.
The management of menorrhagia in secondary care. London: RCOG, 1999.
w3 Guidelines for the management of heavy
menstrual bleeding. Wellington: National Health Committee, New Zealand,
1998.
w4 Lethaby A, Farquhar C, Cooke I. Antifibrinolytics
for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(4):CD000249.
w5 Lethaby A, Irvine G, Cameron I. Cyclical progestogens
for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(2):CD001016.
w6 Beaumont H, Augood C, Duckitt K, Lethaby A.
Danazol for heavy menstrual bleeding. Cochrane Database Syst Rev 2002;(2):CD001017.
w7 Lethaby A, Augood C, Duckitt K. Nonsteroidal
anti-inflammatory drugs for heavy menstrual bleeding Cochrane Database
Syst Rev 2002;(1):CD000400.
w8 Iyer V, Farquhar C, Jepson R. Oral contraceptive
pills for heavy menstrual bleeding. Cochrane Database Syst Rev 2000;(2):CD000154.
w9 Lethaby A, Cooke I, Rees M. Progesterone/progestogen
releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database
Syst Rev 2000;(2):CD002126.
w10 Royal College of Obstetrics and Gynaecology.
The initial management of menorrhagia. London: RCOG, 1998.
